Non-executive director Guo Huaqing increased his holdings of CARSGEN-B (02171) by 70,000 shares, with a price of 14.8 Hong Kong dollars per share.
On November 6th, non-executive director Guo Huaqing increased his holdings of SciClone Pharmaceuticals-B stocks (02171) by 70,000 shares, at a price of 14.8 Hong Kong dollars per share, for a total amount of 1.036 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on November 6, non-executive director Guo Huaqing increased his holdings of CARSGEN-B (02171) by 70,000 shares, with a price of 14.8 Hong Kong dollars per share, totaling 1.036 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 218 million shares, with a shareholding ratio of 37.72%.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


